Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
β-Arrestin-mediated Signaling Regulates Protein Synthesis
2008 StandoutNobel
$beta;-Adrenergic function in heart muscle disease and heart failure
1985
Arrhythmias and mortality in congestive heart failure
1990
Use of carvedilol in chronic heart failure: Challenges in therapeutic management
1998
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE study)
2001
Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
1995
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
G Protein-coupled Receptor Kinase 5 in Cultured Vascular Smooth Muscle Cells and Rat Aorta
1997 StandoutNobel
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
2007 StandoutNobel
Laparoscopic Gastric Bypass: Development of Technique, Respiratory Function, and Long-Term Outcome
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
1998
Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors
1997 StandoutNobel
Passive epicardial containment prevents ventricular remodeling in heart failure
2000
Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy
1993
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Update on recent clinical trials in congestive heart failure
2000
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Relief of Cardiorespiratory Symptoms and Increased Physical Activity After Surgically Induced Weight Loss
2000
Phosphorylation and Desensitization of the Human β1-Adrenergic Receptor
1995 StandoutNobel
Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment
2003
Insulin induces medial hypertrophy of myocardial arterioles in rats
1995
The Role of Echocardiography in the Diagnosis and Management of Heart Failure
2003
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Successes and failures of current treatment of heart failure
1998
A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives
1997
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
The Management of Chronic Heart Failure
1996
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
Surgery for morbid obesity
2005
Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
1990
Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography
2002
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
2003
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure
1990
The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.
1998
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trial
1994
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
1993
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Left Ventricular Dilatation and the Risk of Congestive Heart Failure in People without Myocardial Infarction
1997
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
1993
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
New Drug Approaches to the Treatment of Heart Failure in Infants and Children
1990
G Protein-coupled Receptor Kinase 3 (GRK3) Gene Disruption Leads to Loss of Odorant Receptor Desensitization
1997 StandoutNobel
Inhibition of Spontaneous β2-Adrenergic Activation Rescues β1-Adrenergic Contractile Response in Cardiomyocytes Overexpressing β2-Adrenoceptor
2000 StandoutNobel
Safety and efficacy of carvedilol in severe heart failure
1997
Double-Blind Placebo-Controlled Study of Ibopamine and Diagoxin in Patients With Mild to Moderate Heart Failure: Results of the Dutch of the Ibopamine Multicenter Trial (DIMT)
1993
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
2008 StandoutNobel
In Vivo Ventricular Gene Delivery of a β-Adrenergic Receptor Kinase Inhibitor to the Failing Heart Reverses Cardiac Dysfunction
2001 StandoutNobel
Rationale for beta-adrenergic blocking drugs in cardiomyopathy
1985
Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
1985
Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.
1986
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
1994 StandoutScienceNobel
Pharmacological and surgical treatment of obesity.
2004
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Midwall Left Ventricular Mechanics
1996
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
1994
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.
1993
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
1984 Standout
Biological Action of Leptin as an Angiogenic Factor
1998 StandoutScience
Plasma norepinephrine in congestive heart failure
1978
Supernormal contractility in primary hypertension without left ventricular hypertrophy.
1988
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease
2004
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia
1986
Effect of local arterial hypotension on cat intestinal capillary permeability
1980
Adrenergic effects on the biology of the adult mammalian cardiocyte.
1992
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
1990
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
1995 StandoutScienceNobel
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
1996
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
1994
Beta-Adrenergic Blockade in Chronic Heart Failure
1998
The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation
2002
Prognostic Value of Bisoprolol-Induced Hemodynamic Effects in Heart Failure During the Cardiac Insufficiency BIsoprolol Study (CIBIS)
1997
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
2009 StandoutNobel
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
2009 StandoutNobel
The PDZ-binding motif of the β 2 -adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes
2003 StandoutNobel
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
Influence of β -Blockers on Mortality in Chronic Heart Failure
2000
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
What Is the Role of β-Adrenergic Signaling in Heart Failure?
2003
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
1985 Standout
Works of I Wallentin being referenced
Usefulness of Atrial Size Inequality as an Indicator of Abnormal Left Ventricular Filling
2005
Effects of Obesity and Weight Loss on Cardiac Function and Valvular Performance
1998
Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study
1997
Beta-blockers in dilated cardiomyopathies: they work
1983
Studies on the Relationship Between Flow Resistance, Capillary Filtration Coefficient and Regional Blood Volume in the Intestine of the Cat
1963
Dyspnoea of cardiac origin in 67 year old men: (2). Relation to diastolic left ventricular function and mass. The study of men born in 1913.
1988
Left ventricular wall stress and systolic function in untreated primary hypertension.
1985
Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.
1980
Left Ventricular Mass in Middle-Aged Men Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors
1983
Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.
1989
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
1975
PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE
1979
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.
1980